Pro Dex Inc PDEX Stock Forecast
AI-powered price prediction and analysis for Pro Dex Inc · Total · absolute moveSwitch to Alpha
See PDEX's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Pro Dex Inc
Pro Dex Inc (PDEX) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.
Latest News
Where PDEX sits on the market map
Surgical & Medical Instruments & Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| PDEX Pro Dex Inc | ▲ | $192M | 14.5x |
| SYK Stryker Corp | ▼ | $108.02B | 29.0x |
| MMM 3m Co | ▼ | $84.82B | 29.2x |
| BSX Boston Scientific Corp | ▼ | $63.97B | 21.9x |
| BDX Becton Dickinson & Co | ▼ | $52.78B | 62.9x |
| MDLN Medline Inc. | ▶ | $47.24B | – |
| RMD Resmed Inc | ▼ | $33.94B | 22.3x |
| DXCM Dexcom Inc | ▼ | $33.10B | 38.5x |
| WST West Pharmaceutical Services Inc | ▼ | $26.37B | 46.7x |
| SOLV Solventum Corp | ▼ | $14.85B | 10.4x |
| BAX Baxter International Inc | ▶ | $13.32B | – |
| PEN Penumbra Inc | ▼ | $12.61B | 98.5x |
| GMED Globus Medical Inc | ▼ | $10.59B | 22.3x |
| GKOS Glaukos Corp | ▲ | $9.77B | – |
| PODD Insulet Corp | ▼ | $9.29B | 23.0x |
| STVN Stevanato Group S.P.A. | ▲ | $5.85B | – |
| HAE Haemonetics Corp | ▼ | $5.52B | 58.6x |
| TFX Teleflex Inc | ▼ | $5.22B | – |
| MMSI Merit Medical Systems Inc | ▼ | $5.20B | 38.9x |
| MMED Minimed Group, Inc. | ▶ | $4.73B | – |
| HTFL Heartflow, Inc. | ▲ | $4.43B | – |
| ICUI Icu Medical Inc/De | ▼ | $4.18B | 298.6x |
| IRTC Irhythm Holdings, Inc. | ▼ | $3.60B | – |
| PLSE Pulse Biosciences, Inc. | ▲ | $3.30B | – |
| ATRC Atricure, Inc. | ▶ | $2.94B | 825.4x |
| UFPT Ufp Technologies Inc | ▶ | $2.25B | 31.2x |
| INSP Inspire Medical Systems, Inc. | ▲ | $2.03B | 14.0x |
| LMAT Lemaitre Vascular Inc | ▶ | $1.89B | 31.1x |
| KMTS Kestra Medical Technologies, Ltd. | ▲ | $1.71B | – |
| ATEC Alphatec Holdings, Inc. | ▲ | $1.69B | – |
| NVCR Novocure Ltd | ▲ | $1.61B | – |
| DRTS Alpha Tau Medical Ltd. | ▲ | $1.19B | – |
| IRMD Iradimed Corp | ▼ | $1.14B | 52.3x |
| TNDM Tandem Diabetes Care Inc | ▲ | $1.11B | – |
| AORT Artivion, Inc. | ▼ | $1.07B | – |
| IART Integra Lifesciences Holdings Corp | ▶ | $1.05B | – |
| PRCT Procept Biorobotics Corp | ▲ | $1.00B | – |
| BVS Bioventus Inc. | ▼ | $943M | 20.0x |
| BBNX Beta Bionics, Inc. | ▲ | $913M | – |
| SIBN Si-Bone, Inc. | ▶ | $873M | – |
| SGP Spyglass Pharma, Inc. | ▲ | $792M | – |
| MDXG Mimedx Group, Inc. | ▶ | $685M | 29.4x |
| KIDS Orthopediatrics Corp | ▼ | $589M | – |
| SSII Ss Innovations International, Inc. | ▲ | $541M | – |
| DCTH Delcath Systems, Inc. | ▲ | $523M | 211.6x |
| TCMD Tactile Systems Technology Inc | ▶ | $508M | 20.4x |
| ANGO Angiodynamics Inc | ▲ | $487M | – |
| BWAY Brainsway Ltd. | ▲ | $463M | – |
| CERS Cerus Corp | ▲ | $455M | – |
| SGHT Sight Sciences, Inc. | ▲ | $454M | – |
| NPCE Neuropace Inc | ▶ | $431M | – |
| RCEL Avita Medical, Inc. | ▲ | $405M | – |
| CARL Carlsmed, Inc. | ▲ | $381M | – |
| OFIX Orthofix Medical Inc. | ▼ | $377M | – |
| EMBC Embecta Corp. | ▶ | $365M | 5.4x |
| OBIO Orchestra Biomed Holdings, Inc. | ▲ | $339M | – |
| CLPT Clearpoint Neuro, Inc. | ▲ | $294M | – |
| ANIK Anika Therapeutics, Inc. | ▼ | $277M | – |
| MOBI Mobia Medical, Inc. | ▼ | $277M | – |
| TMCI Treace Medical Concepts, Inc. | ▲ | $263M | – |
FAQ
Is Pro Dex Inc a good stock to buy?
Our AI analyzes Pro Dex Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Pro Dex Inc predictions?
For PDEX, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 4.0%, measured on 358 forecast dates between 2022-07-28 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 5.0%, measured on 400 forecast dates between 2022-07-28 and 2026-09-15. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Pro Dex Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 15, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Pro Dex Inc? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.